Showing results (11-20 of 200) with videos related to
Sort By:
Pageof 20
Expert Opinion on Investigational Drugs|February 17, 2007
3rd PacRim Breast and Prostate Cancer Meeting. 31 October-4 November 2006, Fraser Island, Queensland, AustraliaPeter J FullerTrends in Endocrinology and Metabolism: TEM|March 30, 2004
Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumoursPeter J Fuller, Simon ChuArthritis and Rheumatism|July 28, 2010
Cytokine-induced increases in ADAMTS-4 messenger RNA expression do not lead to increased aggrecanase activity in ADAMTS-5-deficient miceFraser M Rogerson, Yuen M Chung, Michael E Deutscher, et al.Journal of Gastroenterology|December 13, 2006
Gene expression in the adapting small bowel after massive small bowel resectionLyrissa Baksheev, Peter J FullerMolecular and Cellular Endocrinology|July 26, 2011
Interactions of the mineralocorticoid receptor--within and withoutJun Yang, Peter J FullerInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
Tyrosine Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of Granulosa Cell Tumors of the OvaryStacey Jamieson, Peter J FullerThe Journal of Biological Chemistry|January 27, 2007
ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulfate-rich region of aggrecanCharlotte J East, Heather Stanton, Suzanne B Golub, et al.Hormones & Cancer|May 16, 2013
Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell linesStacey Jamieson, Peter J FullerCurrent Opinion in Oncology|December 25, 2008
Management of granulosa cell tumour of the ovaryStacey Jamieson, Peter J FullerEndocrine Reviews|January 14, 2012
Molecular pathogenesis of granulosa cell tumors of the ovaryStacey Jamieson, Peter J FullerPageof 20